Nemes Rush Group LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History
Nemes Rush Group LLC
- $809 Billion
- Q4 2024
A detailed history of Nemes Rush Group LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Nemes Rush Group LLC holds 15 shares of XBI stock, worth $1,309. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 15
-0.0%
Holding current value
$1,309
Previous $1.42 Million
5.06%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding XBI
# of Institutions
917Shares Held
102MCall Options Held
27.4MPut Options Held
38.6M-
Citigroup Inc11.2MShares$974 Million0.62% of portfolio
-
Morgan Stanley New York, NY10.2MShares$888 Million0.07% of portfolio
-
Goldman Sachs Group Inc New York, NY9.56MShares$834 Million0.14% of portfolio
-
Bank Of America Corp Charlotte, NC8.52MShares$744 Million0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY8.01MShares$699 Million0.06% of portfolio